Irlanda – Vaccinuri – National Contract for Monoclonal Antibody for Respiratory Syncytial Virus (RSV) Passive Immunisation for Infants - Pathfinder Programme 3

There is only one sole supplier of monoclonal antibody approved that has received EMA authorisation. Negotiated National Contract for Monoclonal Antibody for Respiratory Syncytial Virus (RSV) Passive Immunisation for Infants - Pathfinder Programme 3 Sanofi Aventis Ireland Ltd The High Court of Ireland In accordance with National Immunisation Advisory Committee (NIAC) advice, HSE Public Health: National Health Protection, with Access & Integration and the National Women and Infants Health Programme wish to put in place a contract for a monoclonal antibody, Nirsevimab (Beyfontus®) for a third pathfinder immunisation programme to protect all babies from RSV disease born from 1st March 2026 to 28th February 2027. RSV is a common virus that causes respiratory infections in young babies. Babies under three months old get sicker with RSV than older children. Each winter in Ireland one in two newborns babies will get RSV and many will need medical care from their GP or the emergency department of a children’s hospital. Four out of a hundred new born babies are hospitalised due to RSV with some babies needing special treatment in intensive care units. Nirsevimab is currently the best way to protect babies from RSV. This contract will supply 50,000 doses of this drug for passive immunisation over a seven month period during the RSV season. European Dynamics S.A. Negotiated with sole authorised supplier Health Service Executive (HSE) 01 EL301 [telefon eliminat] neg-wo-call selec-w Dublin [email eliminat] 166500 none 0043024G supplies ORG-0003 ORG-0004 HSE ORG-0001 ORG-0002 https://www.hse.ie EUR large CON-0001 [email eliminat] Athens no-eu-funds 32014L0024 1 RE [telefon eliminat] can-standard Oak House, Millennium Park Naas Co. Kildare GRC 08 ••• ••• 20 Dublin 24 ENG no IRL body-pl technical 78754bbd-e24a-40c9-b90d-336fbd35c0b4 29 TEN-0001 eforms-sdk-1.13 Four Courts, Inns Quay, Dublin 7 [email eliminat] RES-0001 HSE 27864 LOT-0001 [telefon eliminat]+01:00 ••• ••• 01+02:00 TPA-0001 190/2026 15125 Kildare D07 WDX8 cost 33651600 false health IE061 12:11:14+01:00 34ca1ef2-9605-4f21-a758-0b107407b32e [telefon eliminat] IE062 tenders 2.3 ted-esen